Does RIZATRIPTAN Cause Product use in unapproved indication? 423 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 423 reports of Product use in unapproved indication have been filed in association with RIZATRIPTAN (RIZATRIPTAN BENZOATE). This represents 14.6% of all adverse event reports for RIZATRIPTAN.
423
Reports of Product use in unapproved indication with RIZATRIPTAN
14.6%
of all RIZATRIPTAN reports
0
Deaths
20
Hospitalizations
How Dangerous Is Product use in unapproved indication From RIZATRIPTAN?
Of the 423 reports, 20 (4.7%) required hospitalization, and 1 (0.2%) were considered life-threatening.
Is Product use in unapproved indication Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RIZATRIPTAN. However, 423 reports have been filed with the FAERS database.
What Other Side Effects Does RIZATRIPTAN Cause?
Drug ineffective (1,041)
Off label use (522)
Nausea (447)
Headache (335)
Hyperhidrosis (333)
Migraine (329)
Sedation (320)
Nightmare (314)
Drug intolerance (240)
Nephrolithiasis (240)
What Other Drugs Cause Product use in unapproved indication?
DUPILUMAB (33,452)
DICLOFENAC (12,197)
METHOTREXATE (8,930)
PREDNISONE (7,625)
RITUXIMAB (7,519)
MYCOPHENOLATE MOFETIL (5,910)
ACETAMINOPHEN (5,819)
CYCLOPHOSPHAMIDE (5,750)
RISPERIDONE (5,551)
TACROLIMUS (5,057)
Which RIZATRIPTAN Alternatives Have Lower Product use in unapproved indication Risk?
RIZATRIPTAN vs ROACTEMRA
RIZATRIPTAN vs ROCURONIUM
RIZATRIPTAN vs ROFECOXIB
RIZATRIPTAN vs ROFLUMILAST
RIZATRIPTAN vs ROLAPITANT